Boston Scientific Corporation

Boston Scientific to Add New European Institute for Therapy Advancement Campus to Global Medical Education Network

Natick, Massachusetts and Paris (ots/PRNewswire) - - New Second-Generation Training Center in Brussels to Help Medical Professionals Advance Standard of Patient Care Boston Scientific Corporation (NYSE: BSX) today announced plans for the construction of a new state-of-the art medical training facility in Brussels, Belgium designed to help health care professionals advance the standard of patient care. The Company expects the new addition to be completed in early 2007. "From our work at the Institute for Therapy Advancement over the past five years, we have learned which type of training is important to health care professionals," said Professor Jean Marco of the Institute Pasteur in Toulouse. "This experience is a guide to building a second generation Institute that better addresses the specific needs of medical professionals at all levels." The new facility will be able to host thousands of health care professionals annually and will offer medical education and skills training on the latest developments in the medical device field. Founded in 2000 by Guidant, the Institute for Therapy Advancement is a leader in medical education programs that address the real-world practical needs of health care professionals and is now part of a Boston Scientific global medical education network with campuses in Tokyo, Japan, Brussels, Belgium and St. Paul, Minnesota in the United States. Boston Scientific acquired Guidant on April 21. "This new Institute for Therapy Advancement facility is a reflection of our commitment to helping physicians put into practice the latest developments and guidelines," said Jeff Goodman, Senior Vice President and President of International of Boston Scientific. "We understand that time is a scarce resource for clinicians today so the effectiveness and efficiency of continued medical education has become increasingly important." Programs at the Institute for Therapy Advancement are designed and taught by independent physician experts. As a result, the majority of programs hosted by the Institute are CME accredited. More than 15,000 health care professionals have participated in the Institute's programs to date. Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com. This press release contains forward-looking statements. The Company wishes to caution the reader of this press release that actual results may differ from those discussed in the forward-looking statements and may be adversely affected by, among other things, risks associated with the regulatory approval process, reimbursement policies, commercialization of new technologies, education and training of health care professionals, litigation, the Company's overall business strategy and other factors described in the Company's filings with the Securities and Exchange Commission. NATICK, Massachusetts and PARIS, May 17 /PRNewswire/ -- ots Originaltext: Boston Scientific Corporation Im Internet recherchierbar: http://www.presseportal.ch Contact: For further information, please contact: Geraldine Varoqui, Boston Scientific PR Manager International, Tel: +49-2102-489-461, varoquig@bsci.com; Maren Koban, BSC press office, Tel: +44-(0)20-7973-4497, mkoban@hillandknowlton.com

Das könnte Sie auch interessieren: